Release of our first CSR Report!
We’re excited to announce the publication of our first CSR Report!
HTL Biotechnology has 45 years track record in Polynucleotides (PDRN-PN) production.
We are recognised for being able to provide Polynucleotides for both topical and injectable applications, with a very low level of impurities.
Features
Advantages
Applications
Cosmetics
Moisture retention
Free radical scavenger
Anti-peroxidizing activities
Pharma
Viscoelastic gel
Healing & stimulant activities
Constitutive elements for tissue regeneration